Seth M. Bloom

Seth M. Bloom is a physician-scientist holding the position of Instructor in Medicine at Harvard Medical School and working within the Infectious Diseases Division at Massachusetts General Hospital. He is also an Associate Member at the Ragon Institute of Mass General Brigham, MIT, and Harvard. His work bridges clinical medicine and basic science research with a strong focus on global health applications.

Education:

• BA in Biology, Washington University, St. Louis (2004)
• MD, PhD in Medicine and Microbiology, Washington University School of Medicine, St. Louis (2012)
• Internal Medicine Residency, Barnes-Jewish Hospital & Washington University, St. Louis (2015)
• Infectious Diseases Fellowship, Massachusetts General Hospital and Brigham & Women's Hospital, Boston (2017)

Dr. Bloom's research program centers on understanding how the cervicovaginal microbiota and metabolome influence genital tract health, mucosal immunity, and risk for diseases such as HIV, bacterial vaginosis, and cervical cancer. His laboratory seeks to elucidate fundamental mechanisms of microbiologic function and human disease, with the ultimate goal of identifying novel therapies to modify microbiota composition. This research has significant implications for genital tract health globally but holds particular importance for African populations, which face a high burden of microbiota-associated diseases. To address this epidemiology, Dr. Bloom maintains several international collaborations with researchers across Africa.

Analysis of his recent publications reveals a strong focus on the vaginal microbiome, particularly the roles of Lactobacillus species (including L. crispatus and L. iners) in maintaining vaginal health and preventing disease. His work combines clinical studies, microbiome analysis, metabolomics, and therapeutic development, with an emphasis on translating basic science discoveries into interventions that can improve women's health globally. A notable trend in his research is the development of biotherapeutic approaches for microbiome modulation and the identification of specific metabolic pathways that can be targeted for therapeutic intervention.

Scientific Recognition:

• 2018 Travel Scholarship, HIV Research for Prevention (HIVR4P)
• 2021 Scholarship Award, Keystone eSymposia: The Microbiome: From Mother to Child
• 2023 Emerging Generation Award, American Society for Clinical Investigation (ASCI)
• 2024 Scholarship Award, HIV Research for Prevention (HIVR4P)
• 2027 Vice Chair, Gordon Research Conference (GRC) on Lactic Acid Bacteria

Dr. Bloom serves as Principal Investigator on NIH K08 grant K08AI171166 (2023-2028) titled 'Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammation.' This research represents a significant investment in his innovative approach to understanding host-microbiome interactions. While specific advising information isn't provided in the available materials, his extensive publication record suggests active mentorship of junior researchers in his laboratory.

His research program operates at the intersection of the Massachusetts General Hospital Infectious Diseases Division, the Ragon Institute, and international research sites, particularly in Africa. This collaborative structure enables him to conduct both basic mechanistic studies and clinical translational research with direct relevance to global health challenges. His laboratory appears to integrate multiple disciplines including microbiology, immunology, metabolomics, and clinical infectious diseases to tackle complex questions about host-microbiome interactions.